A detailed history of Hhm Wealth Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hhm Wealth Advisors, LLC holds 1,966 shares of BMY stock, worth $79,524. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,966
Previous 2,124 7.44%
Holding current value
$79,524
Previous $108,000 1.85%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $7,580 - $8,595
-158 Reduced 7.44%
1,966 $106,000
Q4 2023

Feb 05, 2024

SELL
$48.48 - $57.85 $13,332 - $15,908
-275 Reduced 11.46%
2,124 $108,000
Q3 2023

Nov 03, 2023

BUY
$57.89 - $64.73 $11,867 - $13,269
205 Added 9.34%
2,399 $139,000
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $41,411 - $45,981
650 Added 42.1%
2,194 $140,000
Q1 2023

May 02, 2023

BUY
$65.71 - $74.53 $24,181 - $27,427
368 Added 31.29%
1,544 $107,000
Q3 2022

Nov 04, 2022

SELL
$0.13 - $76.84 $68 - $40,341
-525 Reduced 30.86%
1,176 $84,000
Q2 2022

Aug 08, 2022

BUY
$72.62 - $79.98 $36,745 - $40,469
506 Added 42.34%
1,701 $131,000
Q1 2022

Apr 27, 2022

SELL
$61.48 - $73.72 $100,212 - $120,163
-1,630 Reduced 57.7%
1,195 $87,000
Q4 2021

Feb 03, 2022

BUY
$53.63 - $62.52 $15,552 - $18,130
290 Added 11.44%
2,825 $176,000
Q3 2021

Nov 02, 2021

SELL
$59.17 - $69.31 $355 - $415
-6 Reduced 0.24%
2,535 $150,000
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $10,394 - $11,518
-181 Reduced 6.65%
2,541 $153,000
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $27,410 - $32,045
-500 Reduced 15.52%
2,722 $160,000
Q1 2020

May 12, 2020

BUY
$46.4 - $67.43 $149,500 - $217,259
3,222 New
3,222 $180,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hhm Wealth Advisors, LLC Portfolio

Follow Hhm Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hhm Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hhm Wealth Advisors, LLC with notifications on news.